Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Arrowhead, Astellas, Aum, Bridge, Celltrion Healthcare, Genfleet, Index, Junshi, Kyowa Kirin, Novavax, Nuance, Organon, Samsung, SK, Verona.